GENE ONLINE|News &
Opinion
Blog

2020-09-27| SpecialTechnology

Combining the Power of miRNAs and Nanotechnology to Prevent Osteoarthritis Progression

by GeneOnline
Share To
miRNAs belong to the category of non-coding RNAs. They block the expression of a gene either by binding to its specific mRNA and degrading it or by preventing the translation of the specific mRNA. More than 1900 miRNAs have been discovered to date in humans, and many of them have been implicated in various human diseases. Changes in the expression of miRNA have been involved in diseases like cancer, obesity, cardiovascular diseases, and osteoarthritis (OA).
Several miRNAs have been identified that are differentially expressed in OA . One of the first miRNA that has been linked to OA pathology is miRNA-140.

GO Prime with only $1.49 now

LATEST
Merck’s KEYNOTE-522 Success; BMS Licenses PRX019, Prothena Gets $80M
2024-06-19
Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial
2024-06-18
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
EVENT
Scroll to Top